SI-BONE, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SIBN research report →
Companysi-bone.com
SI-BONE, Inc. , a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures.
- CEO
- Laura A. Francis
- IPO
- 2018
- Employees
- 349
- HQ
- Santa Clara, CA, US
Price Chart
Valuation
- Market Cap
- $657.26M
- P/E
- -39.01
- P/S
- 3.19
- P/B
- 3.64
- EV/EBITDA
- -85.98
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 79.59%
- Op Margin
- -9.67%
- Net Margin
- -8.10%
- ROE
- -9.56%
- ROIC
- -8.99%
Growth & Income
- Revenue
- $200.93M · 20.19%
- Net Income
- $-18,908,000 · 38.83%
- EPS
- $-0.44 · 41.33%
- Op Income
- $-22,330,000
- FCF YoY
- 60.35%
Performance & Tape
- 52W High
- $21.89
- 52W Low
- $11.48
- 50D MA
- $13.33
- 200D MA
- $15.83
- Beta
- 0.67
- Avg Volume
- 739.44K
Get TickerSpark's AI analysis on SIBN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | FRANCIS LAURA | sell | 3,893 |
| May 18, 26 | FRANCIS LAURA | sell | 2,236 |
| May 18, 26 | FRANCIS LAURA | sell | 1,973 |
| May 18, 26 | FRANCIS LAURA | sell | 3,652 |
| May 18, 26 | FRANCIS LAURA | sell | 3,203 |
| May 18, 26 | PISETSKY MICHAEL A. | sell | 1,872 |
| May 18, 26 | PISETSKY MICHAEL A. | sell | 1,854 |
| May 18, 26 | Maheshwari Anshul | sell | 2,477 |
| May 18, 26 | Maheshwari Anshul | sell | 2,189 |
| May 4, 26 | DUNN JEFFREY W | sell | 337 |
Our SIBN Coverage
We haven't published any research on SIBN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SIBN Report →